ARTHRITIS FOUNDATION for ARTHRITIS FOUNDATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 1600 Patients' Access to Treatments Act HR 6 21st Century Cures/Innovation for Healthier Americans HR 1859/S2782 Physician Workforce/Pediatric Subspecialty Loan Repayment Biosimilars guidance, oversight FDA, FDA Reauthorizations HR 2029 National Defense Authorization Act National Pain Strategy Step Therapy Osteoarthritis Research HR 2646, Helping Families in Mental Health Crisis Act Affordable Care Act, repeal and replace
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA HYDE | Director, Health Policy and Federal Affairs |
| SANDIE J. PREISS | Vice President, Advocacy and Access |
Medicare/Medicaid MMM
Medicare Part B and D Telemedicine Medicaid CHIP CHIP Re-authorization S.776 Medication Therapy Management Empowerment Act of 2015 HR 2624/S1488 Part D Beneficiary Appeals Fairness Act Part B proposal HR5122
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA HYDE | Director, Health Policy and Federal Affairs |
| SANDIE J. PREISS | Vice President, Advocacy and Access |
Budget/Appropriations BUD
FY 17 & FY 18 appropriations for HHS, CDC, NIH, DOD, FDA, VA Budget Control Act Bipartisan Budget Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA HYDE | Director, Health Policy and Federal Affairs |
| SANDIE J. PREISS | Vice President, Advocacy and Access |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.